HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MIRXES-B

59.900

-1.900-3.07%

Volume:823.20K

Turnover:49.46M

Market Cap:16.53B

PE:-77.89

High:62.150

Open:62.150

Low:59.000

Close:61.800

52wk High:77.300

52wk Low:27.050

Shares:276.00M

HK Float Shares:276.00M

Volume Ratio:1.56

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.769

ROE:--

ROA:-51.53%

PB:20.37

PE(LYR):-77.89

PS:100.39

Loading ...

Overview Company News Filings

Mirxes Holding (SEHK:2629): Evaluating Valuation After Recent Share Price Momentum

Simply Wall St.

Mirxes Narrows H1 Loss

MT Newswires Live

MIRXES-B (02629) Reports Interim Results with Net Loss of US$28.35 Million Attributable to Shareholders, Narrowing 36.22% Year-on-Year

Hong Kong Stock Alert | MIRXES-B (02629) Surges Over 8% to New High as Company Enters Indonesian Market Through Blood-Based microRNA Detection Equipment Deployment

BRIEF-MiRXES Holding Says Unit Enters MoU With PT Diastika Biotekindo

MIRXES-B (02629) Subsidiary Enters Memorandum of Understanding with Indonesian Listed Company

Mirxes Holding Co Ltd - Unit Enters Mou With PT Diastika Biotekindo

THOMSON REUTERS

Mirxes Holding - Mou to Collaborate on Registration and Commercialiazation of Diagnostic Tests in Indonesia, Others

THOMSON REUTERS

MIRXES-B (02629) Surges Nearly 9% to Record High, Company Shows Significant Advantages in miRNA-Based Early Cancer Detection

Mirxes Holding Co. Ltd. Announces Relocation of Singapore Head Office to New Address

Mirxes Holding Co. Ltd. Conducted Annual General Meeting

Hong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut

MT Newswires Live

BUZZ-MiRXES, Hengrui Pharmaceuticals soar on Hong Kong debut

HK Movers | Singapore Biotech Start-up Mirxes Rises 30% in Hong Kong Debut

Tiger Newspress

Jiangsu Hengrui, Mirxes debuts cap strong week for Hong Kong listings

Mirxes' Hong Kong IPO Nets HK$881 Million

Mirxes Shares Jump 24% on Hong Kong Debut

Stock Track | MIRXES-B Soars 33.26% on Hong Kong Debut, Opening 24.5% Above Offer Price

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02629/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":59.9,"timestamp":1763107691007,"preClose":61.8,"halted":0,"volume":823200,"delay":0,"floatShares":276000000,"shares":276000000,"eps":-0.76899,"marketStatus":"Closed","change":-1.9,"latestTime":"11-14 16:08:11","open":62.15,"high":62.15,"low":59,"amount":49456525,"amplitude":0.050971,"askPrice":59.9,"askSize":700,"bidPrice":59.65,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-0.558151,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1763343000000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":61.8,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"volumeRatio":1.561812,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276000000,"roa":"-51.53%","roe":"--","lyrEps":-0.76899,"volumeRatio":1.561812,"shares":276000000,"dividePrice":0,"high":62.15,"amplitude":0.050971,"preClose":61.8,"low":59,"week52Low":27.05,"pbRate":"20.37","psRate":"100.39","week52High":77.3,"institutionHeld":0,"latestPrice":59.9,"committee":-0.076923,"eps":-0.76899,"divideRate":0,"volume":823200,"delay":0,"ttmEps":-0.558151,"open":62.15,"prevYearClose":23.3,"prevWeekClose":63.85,"prevMonthClose":67.95,"prevQuarterClose":61.4,"fiveDayClose":63.85,"twentyDayClose":70.6,"sixtyDayClose":48.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02629\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02629","date":"2025-11-13","current":-107.318629,"percent":0.252101,"low":-34.231253,"twenty":-29.342142,"median":-16.014471,"eighty":-11.200928,"high":-10.373055,"avg":-18.871164,"sd":8.301158,"marketCap":16889768010},"quantilePoints":[{"date":"2025-05-30","current":-10.615633,"twenty":-10.820807,"median":-10.729406,"eighty":-10.614136,"marketCap":7683833445},{"date":"2025-06-06","current":-10.752673,"twenty":-10.811558,"median":-10.713624,"eighty":-10.576495,"marketCap":7789091437},{"date":"2025-06-13","current":-10.566273,"twenty":-10.761884,"median":-10.608146,"eighty":-10.555773,"marketCap":7657518947},{"date":"2025-06-20","current":-12.580768,"twenty":-10.923966,"median":-10.686264,"eighty":-10.56693,"marketCap":9117973591},{"date":"2025-06-27","current":-12.5082,"twenty":-12.340962,"median":-10.752673,"eighty":-10.581112,"marketCap":9065344595},{"date":"2025-07-04","current":-11.927039,"twenty":-12.355485,"median":-10.862871,"eighty":-10.586526,"marketCap":8644312625},{"date":"2025-07-11","current":-11.200931,"twenty":-12.261215,"median":-11.092147,"eighty":-10.600008,"marketCap":8118022663},{"date":"2025-07-18","current":-11.402889,"twenty":-12.217621,"median":-11.255392,"eighty":-10.612638,"marketCap":8262752403},{"date":"2025-07-25","current":-11.182791,"twenty":-12.077376,"median":-11.219171,"eighty":-10.651065,"marketCap":8104865414},{"date":"2025-08-01","current":-11.128301,"twenty":-11.949795,"median":-11.200931,"eighty":-10.68858,"marketCap":8065393667},{"date":"2025-08-08","current":-11.930929,"twenty":-11.952128,"median":-11.246394,"eighty":-10.71678,"marketCap":8646944075},{"date":"2025-08-15","current":-16.088166,"twenty":-12.119645,"median":-11.255421,"eighty":-10.743366,"marketCap":11636271059},{"date":"2025-08-22","current":-16.714103,"twenty":-12.435432,"median":-11.355275,"eighty":-10.780307,"marketCap":12057303029},{"date":"2025-08-29","current":-19.927844,"twenty":-12.534962,"median":-11.42267,"eighty":-10.837215,"marketCap":11841524145},{"date":"2025-09-05","current":-19.639174,"twenty":-15.876379,"median":-11.649361,"eighty":-10.890619,"marketCap":11678374256},{"date":"2025-09-12","current":-19.500462,"twenty":-16.755738,"median":-11.763715,"eighty":-10.953665,"marketCap":11578379164},{"date":"2025-09-19","current":-23.413745,"twenty":-18.486553,"median":-11.918008,"eighty":-11.048541,"marketCap":13880897747},{"date":"2025-09-26","current":-25.667378,"twenty":-19.506384,"median":-11.983928,"eighty":-11.09201,"marketCap":15222937150},{"date":"2025-10-03","current":-33.789751,"twenty":-19.751895,"median":-12.054377,"eighty":-11.092062,"marketCap":20046350866},{"date":"2025-10-10","current":-31.081374,"twenty":-21.012535,"median":-12.217733,"eighty":-11.099357,"marketCap":18433897286},{"date":"2025-10-17","current":-30.795303,"twenty":-24.490925,"median":-12.444526,"eighty":-11.135571,"marketCap":18242589234},{"date":"2025-10-24","current":-29.480903,"twenty":-26.341784,"median":-12.526178,"eighty":-11.168279,"marketCap":17463692166},{"date":"2025-10-31","current":-31.356875,"twenty":-27.937945,"median":-12.547947,"eighty":-11.182791,"marketCap":18570545895},{"date":"2025-11-07","current":-29.443096,"twenty":-29.330719,"median":-14.698348,"eighty":-11.200916,"marketCap":17450027305},{"date":"2025-11-13","current":-28.515386,"twenty":-29.342142,"median":-16.014471,"eighty":-11.200928,"marketCap":16889768010}],"updateTime":1763106289280},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2567136185","title":"Mirxes Holding (SEHK:2629): Evaluating Valuation After Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2567136185","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567136185?lang=en_us&edition=fundamental","pubTime":"2025-09-14 01:08","pubTimestamp":1757783301,"startTime":"0","endTime":"0","summary":"The recent movement in Mirxes Holding (SEHK:2629) has prompted a fresh round of questions for investors evaluating their next step. There has not been a single headline event driving this shift, but the activity itself is drawing attention and raising curiosity. With no major announcements or clear news story, many are now wondering whether the latest stock moves signal a change in how the market views the company’s prospects, or if it is simply a pause before new catalysts appear.\n\nStepping...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2629/mirxes-holding-shares/news/mirxes-holding-sehk2629-evaluating-valuation-after-recent-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2629/mirxes-holding-shares/news/mirxes-holding-sehk2629-evaluating-valuation-after-recent-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2562206600","title":"Mirxes Narrows H1 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2562206600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562206600?lang=en_us&edition=fundamental","pubTime":"2025-08-26 12:03","pubTimestamp":1756181037,"startTime":"0","endTime":"0","summary":"Mirxes Holding Company  reported a loss attributable to equity shareholders of $28.4 million for the first half of 2025, compared with a loss of $44.5 million a year earlier, according to a Monday Hong Kong bourse filing.Loss per share came in at $0.185, compared with $0.370 in the prior-year period.Revenue rose to $10.5 million from $9.6 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1189271751","title":"MIRXES-B (02629) Reports Interim Results with Net Loss of US$28.35 Million Attributable to Shareholders, Narrowing 36.22% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1189271751","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189271751?lang=en_us&edition=fundamental","pubTime":"2025-08-25 22:54","pubTimestamp":1756133681,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) announced its interim results for 2025, reporting revenue of US$10.5 million, representing a 9.4% year-on-year increase. The company recorded a net loss attributable to equity...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1165381116","title":"Hong Kong Stock Alert | MIRXES-B (02629) Surges Over 8% to New High as Company Enters Indonesian Market Through Blood-Based microRNA Detection Equipment Deployment","url":"https://stock-news.laohu8.com/highlight/detail?id=1165381116","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165381116?lang=en_us&edition=fundamental","pubTime":"2025-08-18 10:52","pubTimestamp":1755485538,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) surged over 8%, reaching an intraday high of HK$47.8 and setting a new listing record. As of the latest update, the stock was up 7.28% at HK$47.38, with a turnover of HK$14.1342...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2559091056","title":"BRIEF-MiRXES Holding Says Unit Enters MoU With PT Diastika Biotekindo","url":"https://stock-news.laohu8.com/highlight/detail?id=2559091056","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559091056?lang=en_us&edition=fundamental","pubTime":"2025-08-15 23:23","pubTimestamp":1755271424,"startTime":"0","endTime":"0","summary":"BRIEF-MiRXES Holding Says Unit Enters MoU With PT Diastika BiotekindoAug 15  - MiRXES Holding Co Ltd 2629.HK:UNIT ENTERS MOU WITH PT DIASTIKA BIOTEKINDOMOU TO COLLABORATE ON REGISTRATION AND COMMERCIALIAZATION OF DIAGNOSTIC TESTS IN INDONESIA, OTHERSFurther company coverage: 2629.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U61G5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"1196462567","title":"MIRXES-B (02629) Subsidiary Enters Memorandum of Understanding with Indonesian Listed Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1196462567","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196462567?lang=en_us&edition=fundamental","pubTime":"2025-08-15 20:54","pubTimestamp":1755262457,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) announced that its indirect wholly-owned subsidiary MiRXES PTE. LTD. has recently entered into a memorandum of understanding with PT DIASTIKA BIOTEKINDO, a company listed on the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2559914848","title":"Mirxes Holding Co Ltd - Unit Enters Mou With PT Diastika Biotekindo","url":"https://stock-news.laohu8.com/highlight/detail?id=2559914848","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559914848?lang=en_us&edition=fundamental","pubTime":"2025-08-15 20:47","pubTimestamp":1755262073,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U61G5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2559891481","title":"Mirxes Holding - Mou to Collaborate on Registration and Commercialiazation of Diagnostic Tests in Indonesia, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2559891481","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559891481?lang=en_us&edition=fundamental","pubTime":"2025-08-15 20:47","pubTimestamp":1755262073,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nFWN3U61G5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02629","BK1161"],"gpt_icon":0},{"id":"1108952452","title":"MIRXES-B (02629) Surges Nearly 9% to Record High, Company Shows Significant Advantages in miRNA-Based Early Cancer Detection","url":"https://stock-news.laohu8.com/highlight/detail?id=1108952452","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108952452?lang=en_us&edition=fundamental","pubTime":"2025-08-15 11:08","pubTimestamp":1755227298,"startTime":"0","endTime":"0","summary":"MIRXES-B (02629) surged nearly 9%, reaching a high of HK$40.66 to set a new listing record, representing over 70% gain from its IPO price of HK$23.3. As of press time, the stock was up 8.96% at...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629","BK1161"],"gpt_icon":0},{"id":"2548077895","title":"Mirxes Holding Co. Ltd. Announces Relocation of Singapore Head Office to New Address","url":"https://stock-news.laohu8.com/highlight/detail?id=2548077895","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548077895?lang=en_us&edition=fundamental","pubTime":"2025-07-02 18:52","pubTimestamp":1751453557,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd. announced that its principal place of business and head office in Singapore will relocate to 2 Tukang Innovation Grove, #09-02 JTC MedTech Hub, Singapore 618305, effective July 2, 2025. The announcement was made by the company's board of directors, led by Executive Director and CEO Dr. ZHOU Lihan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief on July 02, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250702:nNDL5CSSCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2546204790","title":"Mirxes Holding Co. Ltd. Conducted Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546204790","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546204790?lang=en_us&edition=fundamental","pubTime":"2025-06-27 16:42","pubTimestamp":1751013756,"startTime":"0","endTime":"0","summary":"Mirxes Holding Co. Ltd. held its Annual General Meeting on June 27, 2025. During the meeting, several proposals were put forward and approved. These included the re-election of Dr. TOO Heng Phon as a non-executive director and the re-appointment of KPMG as the auditor of the company, with authorization for the board to determine the auditor's remuneration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirxes Holding Co. Ltd. published the original content used to generate this news brief on June 27, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250627:nNDL5x8FBm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02629"],"gpt_icon":0},{"id":"2537518576","title":"Hong Kong Stocks End Week Higher; Hengrui Pharma, Mirxes Surge in Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2537518576","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537518576?lang=en_us&edition=fundamental","pubTime":"2025-05-23 16:48","pubTimestamp":1747990101,"startTime":"0","endTime":"0","summary":"Hong Kong stocks rose slightly on Friday to close the week in green, buoyed by multiple strong market debuts.The Hang Seng Index edged up 0.2%, or 56.95 points, to end at 23,601.26. The Hang Seng China Enterprises Index rose 0.3%, or 26.22 points, to 8,583.86.Two firms saw a stellar trading debut on the Hong Kong bourse on Friday.Singapore-headquartered micro ribonucleic acid technology company Mirxes Holding  finished at HK$30 per share, up almost 29% from its IPO price of HK$23.30.Jiangsu Hengrui Pharmaceuticals  closed at HK$55.15 per share, up 25% from its IPO price of HK$44.05.Earlier this week, CATL  also made a strong market debut. The battery giant raised over HK$35 billion from its Hong Kong IPO, reportedly the world's largest listing so far this year, according to Reuters.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02833","LU1781817850.SGD","513600","IE00BPRC5H50.USD","MCHmain","LU0128522157.USD","LU1813983027.USD","LU2476274720.SGD","LU1969619763.USD","LU0516423091.SGD","SG9999001846.SGD","LU2298064838.USD","LU2097828557.USD","HSI","LU2778985437.USD","01276","LU0359201612.USD","BK0188","LU1023057109.AUD","600276","LU0164865239.USD","LU2153591404.USD","LU2242644610.SGD","02629","EVS.SI","BK0060","LU0823414478.USD","BK0183","LU1051769294.HKD","HHImain","LU0455707207.USD","MHImain","LU0348805143.USD","LU0607220059.USD","LU1979443071.USD","LU2039709279.SGD","IE00B543WZ88.USD","LU1580142542.USD","LU2148510915.USD","LU1997245177.USD","IE0003851619.USD","LU2580892789.USD","LU1880383366.USD","LU0047713382.USD","LU1064131003.USD","LU0106252389.USD","LU0449509016.USD","LU1769817096.USD"],"gpt_icon":1},{"id":"2537703159","title":"BUZZ-MiRXES, Hengrui Pharmaceuticals soar on Hong Kong debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2537703159","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537703159?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:46","pubTimestamp":1747968388,"startTime":"0","endTime":"0","summary":"BUZZ-MiRXES, Hengrui Pharmaceuticals soar on Hong Kong debut** MiRXES Holding 2629.HK climbs to HK$31.95 on HK debut, up 37.1% from offer price of HK$23.30** Stock last up 31.8%, outpacing Hang Seng Index's .HSI 0.5% gain and Hang Seng Biotech index's .HSHKBIO 2.3% jump** Singapore-headquartered micro ribonucleic acid  tech co, which specialises in early cancer detection and precision medicine, sells 46.6 mln shares in global offering, raising HK$1.09 bln  for R&D, manufacturing, commercialisation of core product** Jiangsu Hengrui Pharmaceuticals 1276.HK jumps to HK$60.5 on HK debut, up 37.3% from offer price of HK$44.05** Chinese oncology drug developer sells 224.52 mln H-shares, raising HK$9.89 bln  for R&D, constructing  production facilities** Hengrui's Shanghai stock 600276.SS slips 1.6%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL1N3RV01T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0000","02629","BK0006","LU1064131003.USD","LU2328871848.SGD","BK0176","BK0012","LU1580142542.USD","LU1051768304.USD","LU2488822045.USD","LU1515016050.SGD","LU2148510915.USD","600276","BK0010","BK0188","LU1781817850.SGD","600028","BK0025","LU1969619763.USD","01276","BK0015","BK0196","LU1064130708.USD","BK0028","LU0651946864.USD","BK0274","BK0239","BK0275","LU0405327148.USD","BK0060","LU1328615791.USD","LU0405327494.USD","600688","BK0187","BK0183"],"gpt_icon":1},{"id":"1102027175","title":"HK Movers | Singapore Biotech Start-up Mirxes Rises 30% in Hong Kong Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1102027175","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102027175?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:24","pubTimestamp":1747967072,"startTime":"0","endTime":"0","summary":"Singapore biotech start-up  $MIRXES-B(02629)$  rose 29% in Hong Kong debut on Friday.Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 bi","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2537778869","title":"Jiangsu Hengrui, Mirxes debuts cap strong week for Hong Kong listings","url":"https://stock-news.laohu8.com/highlight/detail?id=2537778869","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537778869?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:17","pubTimestamp":1747966636,"startTime":"0","endTime":"0","summary":"UPDATE 2-Jiangsu Hengrui, Mirxes debuts cap strong week for Hong Kong listingsHong Kong sees $6.5 billion in new listings this weekHong Kong IPOs and listings have best start to year since 2021 - LSEG dataDemand strong despite US-China geopolitical tensionsHang Seng Index up 18% in 2025, boosting market activityRecasts, updates share prices, adds Jiangsu Hengrui deal details and comments from paragraphs 8-13By Scott Murdoch and Donny Kwok. HONG KONG, May 23  - Positive trading debuts on Friday for Jiangsu Hengrui Pharmaceuticals 1276.HK and Mirxes Holdings 2629.HK, which raised a combined $1.4 billion in separate listings, capped one of the strongest weeks for Hong Kong's capital markets in the past year.\"While the pipeline for the rest of the year is strong and more high-quality names are looking to list across the region, companies will need to be cognizant of the global market environment and be tactical around windows to come to market","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nL1N3RV01G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","LU0405327148.USD","BK0183","01276","LU1064130708.USD","BK0060","LU1969619763.USD","LU0405327494.USD","LU1064131003.USD","600276","LU2488822045.USD","BK0196","BK0239","BK0028","BK0188","LU1328615791.USD","02629","LU2328871848.SGD","LU2148510915.USD"],"gpt_icon":1},{"id":"2537972195","title":"Mirxes' Hong Kong IPO Nets HK$881 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2537972195","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537972195?lang=en_us&edition=fundamental","pubTime":"2025-05-23 10:02","pubTimestamp":1747965741,"startTime":"0","endTime":"0","summary":"Mirxes Holding  raised HK$880.5 million in net proceeds from its initial public offering in Hong Kong.The Singapore-headquartered micro ribonucleic acid technology company issued 46.6 million shares at HK$23.30 each, according to a Thursday filing with the Hong Kong Exchange.The deal's Hong Kong public offering portion was 25.5 times subscribed, prompting the company to issue 5.87 million shares, up from the 4.66 million shares initially allotted.The international offering portion was 0.98 times subscribed, and the firm issued 40.7 million shares, lower than the initial allocation of 41.9 million.The cornerstone investors subscribed to a total of 19.2 million IPO shares.Mirxes starts trading on the Hong Kong bourse today, May 23.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":1},{"id":"2537974774","title":"Mirxes Shares Jump 24% on Hong Kong Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2537974774","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537974774?lang=en_us&edition=fundamental","pubTime":"2025-05-23 09:47","pubTimestamp":1747964826,"startTime":"0","endTime":"0","summary":"Mirxes (HKG:2629) made an impressive trading debut in Hong Kong on Friday morning as its shares soared over 24% at the opening bell.The Singapore-headquartered micro ribonucleic acid technology company opened at HK$29 per share, well above its IPO price of HK$23.30.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"1123311528","title":"Stock Track | MIRXES-B Soars 33.26% on Hong Kong Debut, Opening 24.5% Above Offer Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1123311528","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123311528?lang=en_us&edition=fundamental","pubTime":"2025-05-23 09:32","pubTimestamp":1747963967,"startTime":"0","endTime":"0","summary":"MIRXES-B  made a spectacular debut on the Hong Kong Stock Exchange, soaring 33.26% in early trading on Friday. The stock opened at HK$29 per share, representing a 24.5% premium over its initial public offering  price of HK$23.30.Mirxes Holding, the parent company of MIRXES-B, successfully completed its IPO and began trading on the Hong Kong market. The strong opening suggests significant investor interest in the company, which likely specializes in biotechnology or medical research given its \"-B","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Stock Track | MIRXES-B Soars 33.26% on Hong Kong Debut, Opening 24.5% Above Offer Price","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02629"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":38,"code":"91000000","status":"200"}]}}